内分泌検査製品市場：製品タイプ別、技術別、適応疾患別、エンドユーザー別、地域別

内分泌検査製品の世界市場は、2025年には149億8,000万米ドルと推定され、2032年には281億1,000万米ドルに達すると予測され、2025～2032年にかけてCAGR9.4％で成長すると予測されます。

図.内分泌検査製品市場シェア（%）、2025年地域別

内分泌検査製品とは、内分泌系の機能検査に使用される体外診断薬のことです。内分泌系は、ホルモンを循環系に直接分泌して遠くの標的臓器を調節する腺からなる調節システムです。内分泌検査製品は、医師がホルモンレベルをモニターし、内分泌疾患をスクリーニングするのに役立ちます。一般的な内分泌検査には、甲状腺機能検査、テストステロン検査、エストロゲン検査、プロラクチン検査、コルチゾール検査、インスリン検査などがあります。糖尿病、甲状腺障害、ホルモン不均衡障害などの内分泌関連疾患の有病率の上昇は、世界的に内分泌検査の需要を押し上げる可能性があります。診断技術の進歩により、臨床検査室における高感度バイオアッセイや高性能内分泌検査用自動化ソリューションの開発が可能になりました。

市場力学

世界の内分泌検査製品市場の成長は、内分泌疾患を発症しやすい高齢者の増加、内分泌疾患に対する認識とスクリーニングの増加、疾患の診断と管理における内分泌機能検査の応用拡大によってもたらされます。しかし、新製品承認のための長くて複雑な規制プロセスや、既存の検査手順の変更に対する消極的な姿勢は、市場の成長を妨げる可能性があります。市場は、精度の向上、1回の検査量の多さ、統合されたインフォマティクスを備えた先進的免疫測定プラットフォームの開発から有利な機会を確認しています。これにより、少量のサンプルで複数のホルモンを同時に検査できるようになります。

本調査の主要特徴

本レポートでは、世界の内分泌検査製品市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

内分泌検査製品の世界市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。

本調査の対象となる主要企業は、Abbott、AB Sciex、Agilent Technologies Inc.、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin S.p.A.、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Inc.、Danaher、Immunodiagnostic Systems、Fujirebio, Inc.などがあります。

本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

内分泌検査製品の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。

利害関係者は、世界の内分泌検査製品市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• ポーター分析
• 合併と買収のシナリオ
• 疫学
• パイプライン分析

第4章 内分泌検査製品市場、製品タイプ別、2020～2032年（10億米ドル）

• イントロダクション
• 機器/分析装置
• 消耗品

第5章 内分泌検査製品市場、技術別、2020～2032年（10億米ドル）

• イントロダクション
• 液体クロマトグラフィー質量分析法
• 免疫測定
• タンデム質量分析法
• センサ技術
• その他

第6章 内分泌検査製品市場、疾患適応症別、2020～2032年（10億米ドル）

• イントロダクション
• 副腎機能不全とアジソン病
• 骨疾患
• がん
• 甲状腺疾患
• その他

第7章 内分泌検査製品市場、エンドユーザー別、2020～2032年（10億米ドル）

• イントロダクション
• 病院
• 臨床検査室
• その他

第8章 内分泌検査製品市場、地域別、2020～2032年（10億米ドル）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• Abbott
• AB Sciex
• Agilent Technologies Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• F.Hoffmann-La Roche Ltd.
• Quest Diagnostics Inc
• Danaher
• Immunodiagnostic Systems
• Fujirebio, Inc.

第10章 アナリストの推奨事項

• 隆盛と衰退
• 一貫型機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global Endocrine Testing Product Market is estimated to be valued at USD 14.98 Bn in 2025 and is expected to reach USD 28.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.

Figure. Endocrine Testing Product Market Share (%), By Region 2025

Endocrine testing product refers to in vitro diagnostics that are used to test the functionality of the endocrine system. Endocrine system is a regulatory system composed of glands that secrete hormones directly into the circulatory system to regulate distant target organs. Endocrine testing products help physicians monitor hormone levels and screen for endocrine disorders. Some common endocrine tests include thyroid function tests, testosterone testing, estrogen testing, prolactin testing, cortisol testing, and insulin testing. Rising prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and hormonal imbalance disorders can boost demand for endocrine testing worldwide. Advancements in diagnostic technologies have enabled the development of sensitive bioassays and automated solutions for high-throughput endocrine testing in clinical laboratories.

Market Dynamics

Global endocrine testing product market growth is driven by growing geriatric population who are more prone to developing endocrine disorders, increasing awareness and screening of endocrine conditions, and expanding applications of endocrine function tests in disease diagnosis and management. However, lengthy and complex regulatory processes for new product approvals and reluctance to change existing testing procedures can hamper the market growth. The market witness lucrative opportunities from the development of advanced immunoassay platforms with improved accuracy, high test volumes per run, and integrated informatics. This allows for the testing of multiple hormones simultaneously using small sample volumes.

Key Features of the Study

This report provides in-depth analysis of the global endocrine testing product market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global endocrine testing product market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, Immunodiagnostic Systems, and Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global endocrine testing product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing product market

Market Segmentation

• By Product Type Insights
  • Instruments/Analyzers
  • Consumables
• By Technology Insights
  • Liquid Chromatography-Mass Spectrometry
  • Immunoassay
  • Tandem Mass Spectroscopy
  • Sensor Technology
  • Others
• By Disease Indication Insights
  • Adrenal Insufficiency and Addison Disease
  • Bone Disorders
  • Cancer
  • Thyroid Disease
  • Others
• By End User Insights
  • Hospitals
  • Clinical Laboratories
  • Others
• Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • AB Sciex
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Quest Diagnostics Inc
  • Danaher
  • Immunodiagnostic Systems
  • Fujirebio, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Endocrine Testing Product Market, By Product Type
  • Endocrine Testing Product Market, By Technology
  • Endocrine Testing Product Market, By Disease Indication
  • Endocrine Testing Product Market, By End User
  • Endocrine Testing Product Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Epidemiology
• Pipeline Analysis

4. Endocrine Testing Product Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Instruments/Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Endocrine Testing Product Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Liquid Chromatography-Mass Spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tandem Mass Spectroscopy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sensor Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Endocrine Testing Product Market, By Disease Indication, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adrenal Insufficiency and Addison Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bone Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Thyroid Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Endocrine Testing Product Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinical Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Endocrine Testing Product Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Sciex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics Inc
• Danaher
• Immunodiagnostic Systems
• Fujirebio, Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us